PD Dr. med Jan Borovicka
chief of service
Gastroenterology/Hepatology · Dept. I
HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
Helbling B, Renner E, Meyer-Wyss B, Esteban A, Mullhaupt B, Dinges S, Wilhelmi M, Gonvers J, Borovicka J, Cerny A, Knöpfli M, Stamenic I, Jochum W, Swiss Association for the Study of the Liver (SASL). HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin. Journal of viral hepatitis 2006; 13:762-9.
Nov 1, 2006HCV-related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon alpha-2a and ribavirin
Nov 1, 2006Journal of viral hepatitis 2006; 13:762-9
Helbling Beat, Renner Eberhard L, Meyer-Wyss Beat, Esteban Alicia, Mullhaupt Beat, Dinges Sabine, Wilhelmi Martin, Gonvers Jean-Jacques, Borovicka Jan, Cerny Andreas, Knöpfli Marina, Stamenic Ivan, Jochum Wolfram, Swiss Association for the Study of the Liver (SASL)
[Helicobacter pylori 2006: how to test, when to treat]
van der Weg B, Meyenberger C, Borovicka J. [Helicobacter pylori 2006: how to test, when to treat]. Praxis 2006; 95:1413-8.
Sep 13, 2006[Helicobacter pylori 2006: how to test, when to treat]
Sep 13, 2006Praxis 2006; 95:1413-8
van der Weg B, Meyenberger Christa, Borovicka Jan
Helicobacter pylori 2006: How to test, when to treat
van der Weg B, Meyenberger C, Borovicka J. Helicobacter pylori 2006: How to test, when to treat. Schweiz Rundsch Med Prax. 2006; 95:1413-1418.
Sep 13, 2006Helicobacter pylori 2006: How to test, when to treat
Sep 13, 2006Schweiz Rundsch Med Prax. 2006; 95:1413-1418
van der Weg B, Meyenberger Christa, Borovicka Jan
Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy
Borovicka J, Binek J, Zuercher U, Dorta G, Bauerfeind P, Ehmann T, Gschossmann J, Netzer P, Neuweiler J, Fischer J, Meyenberger C. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy. Endoscopy 2006; 38:867-72.
Sep 1, 2006Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy
Sep 1, 2006Endoscopy 2006; 38:867-72
Borovicka Jan, Binek Janek, Zuercher Ursula, Dorta G, Bauerfeind P, Ehmann T, Gschossmann J, Netzer P, Neuweiler Jörg, Fischer J, Meyenberger Christa
Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis
Meyer-Wyss B, Renner E, Arn M, Meyenberger C, Borovicka J, Rossi L, Criblez D, Oneta C, Gonvers J, Rammert C, Mullhaupt B, Helbling B, Egger H, Rich P, Swiss Association for the Study of the Liver (SASL). Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis. Journal of viral hepatitis 2006; 13:457-65.
Jul 1, 2006Comparison of two PEG-interferon alpha-2b doses (1.0 or 1.5 microg/kg) combined with ribavirin in interferon-naïve patients with chronic hepatitis C and up to moderate fibrosis
Jul 1, 2006Journal of viral hepatitis 2006; 13:457-65
Meyer-Wyss B, Renner E L, Arn M, Meyenberger Christa, Borovicka Jan, Rossi L, Criblez D, Oneta C, Gonvers J-J, Rammert C, Mullhaupt B, Helbling B, Egger Hp, Rich P, Swiss Association for the Study of the Liver (SASL)
helicobacter pylori: Wann testen, wie testen?
van der Weg B, Meyenberger C, Borovicka J. helicobacter pylori: Wann testen, wie testen?. Hausarztpraxis 2006
Jun 1, 2006helicobacter pylori: Wann testen, wie testen?
Jun 1, 2006Hausarztpraxis 2006
van der Weg B, Meyenberger Christa, Borovicka Jan
The influence of postural changes on gastroesophageal reflux and barrier pressure in nonfasting individuals
Jeske H, Borovicka J, von Goedecke A, Meyenberger C, Heidegger T, Benzer A. The influence of postural changes on gastroesophageal reflux and barrier pressure in nonfasting individuals. Anesthesia and analgesia 2005; 101:597-600, table of contents.
Aug 1, 2005The influence of postural changes on gastroesophageal reflux and barrier pressure in nonfasting individuals
Aug 1, 2005Anesthesia and analgesia 2005; 101:597-600, table of contents
Jeske Hans-Christian, Borovicka Jan, von Goedecke Achim, Meyenberger Christa, Heidegger Thomas, Benzer Arnulf
Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma
Hurschler D, Borovicka J, Neuweiler J, Öhlschlegel C, Sagmeister M, Meyenberger C, Schmid U. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:507-14.
Sep 26, 2003Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma
Sep 26, 2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:507-14
Hurschler Daniel, Borovicka Jan, Neuweiler Jörg, Öhlschlegel Christian, Sagmeister Markus, Meyenberger Christa, Schmid Ulrico
Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
August-Jörg B, Renner E, Weitz M, Meyenberger C, Hermann R, Henz S, Gonvers J, Dufour J, Borovicka J, Swiss Association for the Study of the Liver. Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:455-60.
Aug 23, 2003Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C
Aug 23, 2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:455-60
August-Jörg Barbara S E, Renner Eberhard L, Weitz Manfred, Meyenberger Christa, Hermann Rudolf, Henz Samuel, Gonvers Jean-Jacques, Dufour Jean-François, Borovicka Jan, Swiss Association for the Study of the Liver
[Cholestatic hepatitis. 27-year-old tool engineer]
Gubler C, Borovicka J, Diener P, Meyenberger C. [Cholestatic hepatitis. 27-year-old tool engineer]. Praxis 2003; 92:1269-72.
Jul 16, 2003[Cholestatic hepatitis. 27-year-old tool engineer]
Jul 16, 2003Praxis 2003; 92:1269-72
Gubler Ch, Borovicka Jan, Diener P A, Meyenberger Christa
Perception of gastrointestinal endoscopy by patients and examiners with and without background music
Binek J, Sagmeister M, Borovicka J, Knierim M, Magdeburg B, Meyenberger C. Perception of gastrointestinal endoscopy by patients and examiners with and without background music. Digestion 2003; 68:5-8.
Jan 1, 2003Perception of gastrointestinal endoscopy by patients and examiners with and without background music
Jan 1, 2003Digestion 2003; 68:5-8
Binek Janek, Sagmeister Markus, Borovicka Jan, Knierim Matthias, Magdeburg Bernhard, Meyenberger Christa
Cholestatische Hepatitis
Gubler C, Borovicka J, Diener P, Meyenberger C. Cholestatische Hepatitis. Schweiz Rundsch Med Prax. 2003; 92:1269-1272.
Jan 1, 2003Cholestatische Hepatitis
Jan 1, 2003Schweiz Rundsch Med Prax. 2003; 92:1269-1272
Gubler Christoph, Borovicka Jan, Diener Pierre-André, Meyenberger Christa
Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial
Pescatore P, Jornod P, Borovicka J, Pantoflickova D, Suter W, Meyenberger C, Blum A, Dorta G. Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial. Gastrointestinal endoscopy 2002; 55:348-53.
Mar 1, 2002Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial
Mar 1, 2002Gastrointestinal endoscopy 2002; 55:348-53
Pescatore Paul, Jornod Philippe, Borovicka Jan, Pantoflickova Drahoslava, Suter Walter, Meyenberger Christa, Blum André Louis, Dorta Gian
Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial
Helbling B, Renner E, Sagmeister M, Borovicka J, Steuerwald M, Cathomas G, Reichen J, Dufour J, Gonvers J, Viani F, Stamenic I, Investigators of the Swiss Association for the Study of the Liver. Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial. Hepatology (Baltimore, Md.) 2002; 35:447-54.
Feb 1, 2002Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial
Feb 1, 2002Hepatology (Baltimore, Md.) 2002; 35:447-54
Helbling Beat, Renner Eberhard L, Sagmeister Markus, Borovicka Jan, Steuerwald Michael, Cathomas Gieri, Reichen Jurg, Dufour Jean-François, Gonvers Jean-Jacques, Viani Francesco, Stamenic Ivan, Investigators of the Swiss Association for the Study of the Liver
[Pre- and postoperative transaminase changes within the scope of gastric banding in morbid obesity]
Albert S, Borovicka J, Thurnheer M, Lange J, Meyenberger C. [Pre- and postoperative transaminase changes within the scope of gastric banding in morbid obesity]. Praxis 2001; 90:1459-64.
Aug 30, 2001[Pre- and postoperative transaminase changes within the scope of gastric banding in morbid obesity]
Aug 30, 2001Praxis 2001; 90:1459-64
Albert S, Borovicka Jan, Thurnheer M, Lange Jochen, Meyenberger Christa
Prä- und postoperative Transaminasenveränderungen im Rahmen der Magenbandeinlage bei morbider Adipositas
Albert S, Borovicka J, Thurnheer M, Lange J, Meyenberger C. Prä- und postoperative Transaminasenveränderungen im Rahmen der Magenbandeinlage bei morbider Adipositas. Schweiz. Runsch. Med. Prax. 2001; 90:1459-1464.
Jan 1, 2001Prä- und postoperative Transaminasenveränderungen im Rahmen der Magenbandeinlage bei morbider Adipositas
Jan 1, 2001Schweiz. Runsch. Med. Prax. 2001; 90:1459-1464
Albert S, Borovicka Jan, Thurnheer M, Lange Jochen, Meyenberger Christa
Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor
Borovicka J, Schwizer W, Guttmann G, Hartmann D, Kosinski M, Wastiel C, Bischof-Delaloye A, Fried M. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor. Gut 2000; 46:774-81.
Jun 1, 2000Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor
Jun 1, 2000Gut 2000; 46:774-81
Borovicka Jan, Schwizer W, Guttmann G, Hartmann D, Kosinski M, Wastiel C, Bischof-Delaloye A, Fried M
Cytomegalovirus-induced transient protein-losing hypertrophic gastropathy in an immunocompetent adult
Suter W, Neuweiler J, Borovicka J, Binek J, Fantin A, Meyenberger C. Cytomegalovirus-induced transient protein-losing hypertrophic gastropathy in an immunocompetent adult. Digestion 2000; 62:276-9.
Jan 1, 2000Cytomegalovirus-induced transient protein-losing hypertrophic gastropathy in an immunocompetent adult
Jan 1, 2000Digestion 2000; 62:276-9
Suter W R, Neuweiler Jörg, Borovicka Jan, Binek Janek, Fantin A C, Meyenberger Christa
Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride
Borovicka J, Fried M, Spinas G, Boesiger P, Crelier G, Kreiss C, Fraser R, Kunz P, Lehmann R, Schwizer W. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride. The American journal of gastroenterology 1999; 94:2866-73.
Oct 1, 1999Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride
Oct 1, 1999The American journal of gastroenterology 1999; 94:2866-73
Borovicka Jan, Fried M, Spinas G A, Boesiger P, Crelier G, Kreiss C, Fraser R, Kunz P, Lehmann R, Schwizer W
Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans
Kreiss C, Schwizer W, Borovicka J, Jansen J, Bouloux C, Pignol R, Bischof Delaloye A, Fried M. Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans. Regulatory peptides 1998; 74:143-9.
Jun 30, 1998Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans
Jun 30, 1998Regulatory peptides 1998; 74:143-9
Kreiss C, Schwizer W, Borovicka Jan, Jansen J B, Bouloux C, Pignol R, Bischof Delaloye A, Fried M